Concepedia

Chidamide, a novel histone deacetylase inhibitor, synergistically enhances gemcitabine cytotoxicity in pancreatic cancer cells

Zhixin Qiao, Suping Ren, Weijing Li, Xuanlin Wang, Min He, Yingjie Guo, Liwei Sun, Yuezhong He, Yubin Ge, Qun Yu

Biochemical and Biophysical Research Communications · 2013 · 73 citations · 16 references

DOI

Concepts

References

16

Cancer statistics, 2012

Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2012 · 10.7K citations · Full text

Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation

Deepak Nijhawan, Min Fang, Elie Traer et al. · Genes & Development · 2003 · 586 citations · Full text

Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity

Zhiqiang Ning, Zhibin Li, Michael Newman et al. · Cancer Chemotherapy and Pharmacology · 2011 · 284 citations

, , +9

The epidemiology of pancreatic cancer in the United States: changes below the surface

Yasser H. Shaib, Jessica A. Davila, H. B. EL‐SERAG · Alimentary Pharmacology & Therapeutics · 2006 · 159 citations · Full text

Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine

Massimo Donadelli, Chiara Costanzo, Stefania Beghelli et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 2007 · 156 citations

, , +8